IRIS
CUCCHIARA, VITO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 224
NA - Nord America 187
AS - Asia 103
SA - Sud America 2
AF - Africa 1
Totale 517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 184
IT - Italia 85
SE - Svezia 70
CN - Cina 58
SG - Singapore 29
RU - Federazione Russa 17
DE - Germania 16
FI - Finlandia 9
JP - Giappone 6
GB - Regno Unito 5
IN - India 4
NL - Olanda 4
BE - Belgio 3
CA - Canada 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IE - Irlanda 3
PK - Pakistan 3
FR - Francia 1
HK - Hong Kong 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
NG - Nigeria 1
PL - Polonia 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
UY - Uruguay 1
Totale 517
Salva come PNG Salva come JPEG
Città #
New York 38
Milan 32
Singapore 22
Shanghai 21
Ashburn 19
Boardman 16
Princeton 15
Lawrence 14
Moscow 10
Helsinki 9
Rome 8
Frankfurt am Main 4
Macerata 4
Munich 4
Pune 4
Aci Sant'antonio 3
Athens 3
Birmingham 3
Brussels 3
Dublin 3
Paderborn 3
Bethesda 2
Columbus 2
Florence 2
Guangzhou 2
Jiaxing 2
Limbiate 2
Los Angeles 2
Meda 2
Modena 2
Nowshera 2
Palermo 2
Québec 2
Reston 2
Rockville 2
Shenzhen 2
Turin 2
Verdellino 2
Vigonza 2
Zhengzhou 2
Abuja 1
Amsterdam 1
Ancona 1
Asunción 1
Beijing 1
Bengbu 1
Borås 1
Bratislava 1
Buffalo 1
Council Bluffs 1
Crotone 1
Dallas 1
Fiorano Modenese 1
Freiburg im Breisgau 1
Gaithersburg 1
Genoa 1
Giussano 1
Hoffman 1
Jeddah 1
London 1
Maldonado 1
Naples 1
Neyagawa 1
Nov Dojran 1
Ottawa 1
Padova 1
Prague 1
Quanzhou 1
Romford 1
Santa Clara 1
Seattle 1
Segrate 1
Sesto San Giovanni 1
Stockholm 1
Taizhou 1
Torrile 1
Voorschoten 1
Xi'an 1
Totale 314
Salva come PNG Salva come JPEG
Nome #
IL RUOLO DELLE CELLULE T DI MEMORIA RESIDENTI NEI TESSUTI NEL TUMORE PROSTATICO: IMPLICAZIONI PER GLI ESITI ONCOLOGICI 67
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 40
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 36
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 30
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 28
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 28
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 26
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 25
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 24
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 23
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 22
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 21
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 21
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 19
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 19
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 19
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 19
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 19
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 16
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 16
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 12
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 5
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 3
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 2
SINGLE NUCLEOTIDE POLYMORPHISMS AND RISK OF PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL GENETIC RISK SCORE FOR INDIVIDUALIZED SCREENING AND DIAGNOSTIC PROGRAMMES 2
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 2
Totale 557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 9 2 7 0 3 3 3 0 0 0 3
2022/2023137 36 27 11 13 4 14 5 12 3 3 2 7
2023/2024216 3 18 23 16 17 49 3 19 0 16 17 35
2024/2025174 45 25 32 25 47 0 0 0 0 0 0 0
Totale 557